For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Tafamidis meglumine represents a significant advancement . These groundbreaking therapies protect the transthyretin protein, slowing its damaging build-up and lessening the impact of the condition . Patients are now … Read More